90 related articles for article (PubMed ID: 12944987)
21. A MUC1/IL-18 DNA vaccine induces anti-tumor immunity and increased survival in MUC1 transgenic mice.
Snyder LA; Goletz TJ; Gunn GR; Shi FF; Harris MC; Cochlin K; McCauley C; McCarthy SG; Branigan PJ; Knight DM
Vaccine; 2006 Apr; 24(16):3340-52. PubMed ID: 16472547
[TBL] [Abstract][Full Text] [Related]
22. Antibody and CD8+ T cell responses against HER2/neu required for tumor eradication after DNA immunization with a Flt-3 ligand fusion vaccine.
Orlandi F; Venanzi FM; Concetti A; Yamauchi H; Tiwari S; Norton L; Wolchok JD; Houghton AN; Gregor PD
Clin Cancer Res; 2007 Oct; 13(20):6195-203. PubMed ID: 17947487
[TBL] [Abstract][Full Text] [Related]
23. Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.
Felicetti P; Mennecozzi M; Barucca A; Montgomery S; Orlandi F; Manova K; Houghton AN; Gregor PD; Concetti A; Venanzi FM
Cytotherapy; 2007; 9(1):23-34. PubMed ID: 18236207
[TBL] [Abstract][Full Text] [Related]
24. New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models.
Lopes A; Bastiancich C; Bausart M; Ligot S; Lambricht L; Vanvarenberg K; Ucakar B; Gallez B; Préat V; Vandermeulen G
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795383
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help.
Savelyeva N; King CA; Vitetta ES; Stevenson FK
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10987-92. PubMed ID: 16037207
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes.
De Palma R; Marigo I; Del Galdo F; De Santo C; Serafini P; Cingarlini S; Tüting T; Lenz J; Basso G; Milan G; Zanovello P; Bronte V
Cancer Res; 2004 Nov; 64(21):8068-76. PubMed ID: 15520218
[TBL] [Abstract][Full Text] [Related]
27. 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity.
Kim JH; Chen J; Majumder N; Lin H; Falo LD; You Z
Gene Ther; 2005 Oct; 12(20):1517-25. PubMed ID: 16052205
[TBL] [Abstract][Full Text] [Related]
28. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in mice.
Tormo D; Ferrer A; Bosch P; Gaffal E; Basner-Tschakarjan E; Wenzel J; Tüting T
Cancer Res; 2006 May; 66(10):5427-35. PubMed ID: 16707471
[TBL] [Abstract][Full Text] [Related]
31. Further analysis of protection induced by the MIC3 DNA vaccine against T. gondii: CD4 and CD8 T cells are the major effectors of the MIC3 DNA vaccine-induced protection, both Lectin-like and EGF-like domains of MIC3 conferred protection.
Ismael AB; Hedhli D; Cérède O; Lebrun M; Dimier-Poisson I; Mévélec MN
Vaccine; 2009 May; 27(22):2959-66. PubMed ID: 19428907
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
33. An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53.
Blaszczyk-Thurin M; Ertl IO; Ertl HC
Scand J Immunol; 2002 Oct; 56(4):361-75. PubMed ID: 12234257
[TBL] [Abstract][Full Text] [Related]
34. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.
Prins RM; Bruhn KW; Craft N; Lin JW; Kim CH; Odesa SK; Miller JF; Liau LM
Neurosurgery; 2006 Jan; 58(1):169-78; discussion 169-78. PubMed ID: 16385341
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigen.
Bridle BW; Li J; Jiang S; Chang R; Lichty BD; Bramson JL; Wan Y
J Immunol; 2010 Apr; 184(8):4269-75. PubMed ID: 20237288
[TBL] [Abstract][Full Text] [Related]
36. Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.
Wolchok JD; Srinivasan R; Perales MA; Houghton AN; Bowne WB; Blachere NE
Cancer Immun; 2001 Aug; 1():9. PubMed ID: 12747770
[TBL] [Abstract][Full Text] [Related]
37. Thymic CD8+ T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality.
Wheeler CJ; Black KL; Liu G; Ying H; Yu JS; Zhang W; Lee PK
J Immunol; 2003 Nov; 171(9):4927-33. PubMed ID: 14568975
[TBL] [Abstract][Full Text] [Related]
38. Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: unexpected reactivity to a protein paralogue.
Srinivasan R; Houghton AN; Wolchok JD
Cancer Immun; 2002 Jul; 2():8. PubMed ID: 12747753
[TBL] [Abstract][Full Text] [Related]
39. Coupling and uncoupling of tumor immunity and autoimmunity.
Bowne WB; Srinivasan R; Wolchok JD; Hawkins WG; Blachere NE; Dyall R; Lewis JJ; Houghton AN
J Exp Med; 1999 Dec; 190(11):1717-22. PubMed ID: 10587362
[TBL] [Abstract][Full Text] [Related]
40. Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.
Dutoit V; Herold-Mende C; Hilf N; Schoor O; Beckhove P; Bucher J; Dorsch K; Flohr S; Fritsche J; Lewandrowski P; Lohr J; Rammensee HG; Stevanovic S; Trautwein C; Vass V; Walter S; Walker PR; Weinschenk T; Singh-Jasuja H; Dietrich PY
Brain; 2012 Apr; 135(Pt 4):1042-54. PubMed ID: 22418738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
